NANOSPHERE HEA.SCIENCES

Research NANOSPHERE HEA.SCIENCES (2CG) on Bullrun: market cap EUR 92.48K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker2CG
ExchangeF
CountryCanada
SectorHealthcare
IndustryBiotechnology
CurrencyEUR
Market capEUR 92.48K
Financial periodFY2025
RevenueUSD 0
Net income-USD 83.78K
Free cash flow-USD 22.98K

Valuation Snapshot

latest market cap is EUR 92.48K.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	USD 0	-USD 83.78K	-USD 22.98K	n/a	n/a	USD 1.89K	USD 63.40K	-USD 1.35M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-27	EUR 92.48K	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About NANOSPHERE HEA.SCIENCES

NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences Inc. is headquartered in Vancouver, Canada.

Related stock research

Canada stocks Canada Healthcare stocks A-Z stock index

Other Healthcare stocks

Entheon Biomedical Corp. (1XU) MedMira Inc (47M) BRAXIA SCIENTIFIC CORP. (4960) WAVERLEY PHARMA INC. (5GZ) BioVaxys Technology Corp. (5LB0) GLOW LIFETECH CORP. (9DO) NERVGEN PHARMA CORP. (9UA) AbCellera Biologics Inc (ABCL) Appili Therapeutics Inc (APLI) Arch Biopartners Inc (ARCH) Aurinia Pharmaceuticals Inc (AUPH) Briacell Therapeutics Corp (BCT)

Frequently asked questions

What is NANOSPHERE HEA.SCIENCES's market cap?

NANOSPHERE HEA.SCIENCES's market capitalization is EUR 92.48K.